ATE178798T1 - Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion - Google Patents

Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion

Info

Publication number
ATE178798T1
ATE178798T1 AT95904988T AT95904988T ATE178798T1 AT E178798 T1 ATE178798 T1 AT E178798T1 AT 95904988 T AT95904988 T AT 95904988T AT 95904988 T AT95904988 T AT 95904988T AT E178798 T1 ATE178798 T1 AT E178798T1
Authority
AT
Austria
Prior art keywords
risk
medication
production
prevent
reduce
Prior art date
Application number
AT95904988T
Other languages
English (en)
Inventor
David P Speert
Thomas C Usher
Original Assignee
Novadex Pharm Ltd
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novadex Pharm Ltd, Univ British Columbia filed Critical Novadex Pharm Ltd
Application granted granted Critical
Publication of ATE178798T1 publication Critical patent/ATE178798T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT95904988T 1993-12-30 1994-12-29 Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion ATE178798T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17595693A 1993-12-30 1993-12-30
US08/317,228 US5514665A (en) 1993-12-30 1994-10-03 Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans

Publications (1)

Publication Number Publication Date
ATE178798T1 true ATE178798T1 (de) 1999-04-15

Family

ID=26871719

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95904988T ATE178798T1 (de) 1993-12-30 1994-12-29 Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion

Country Status (10)

Country Link
US (1) US5514665A (de)
EP (1) EP0737072B1 (de)
AT (1) ATE178798T1 (de)
AU (1) AU1377995A (de)
CA (1) CA2180352C (de)
DE (1) DE69417920T2 (de)
DK (1) DK0737072T3 (de)
ES (1) ES2133722T3 (de)
GR (1) GR3032116T3 (de)
WO (1) WO1995017898A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
CA2209342A1 (en) * 1997-06-30 1998-12-30 The University Of British Columbia Use of dextran and other oligomeric saccharides to improve airway clearance
US6339075B1 (en) 1997-06-30 2002-01-15 The University Of British Columbia Use of dextran and other polysaccharides to improve mucus clearance
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US20040224922A1 (en) * 1999-08-26 2004-11-11 Malcolm King Use of charged dextran as a mucoactive agent and methods and pharmaceutical compositions relating thereto
HK1047246A1 (zh) * 1999-08-26 2003-02-14 艾伯塔大学理事会 带电葡聚糖作为粘液活性剂的用途及有关方法和药物组合物
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
US6939668B2 (en) * 2001-05-22 2005-09-06 University Health Network Compositions and methods for treatment of lung transplants
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
EP1531795A4 (de) * 2002-05-02 2011-02-23 Harvard College Formulierungen zur begrenzung der ausbreitung von lungeninfektionen
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) * 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation
RU2007131101A (ru) * 2005-01-21 2009-02-27 Астекс Терапьютикс Лимитед (Gb) Комбинации пиразольных ингибиторов киназы и других средств против злокачественных новообразований
EP4008326A1 (de) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Einwertige metallkationen-trockenpulver zum inhalieren
HK1221175A1 (zh) 2013-04-01 2017-05-26 Pulmatrix Operating Company, Inc. 噻托溴铵乾粉
DE102017115870A1 (de) * 2017-07-14 2019-01-17 Strathmann Gmbh & Co. Kg Immunprophylaxe bei Allgemeininfektionen

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141746A (en) * 1970-05-25 1979-02-27 Schweiger Richard Georg Cellulose sulfate esters
JPS5540568B2 (de) * 1972-10-05 1980-10-18
US4177345A (en) * 1974-07-10 1979-12-04 Schweiger Richard Georg Process for preparing a sulfate ester of a polyhydroxy polymer
US5157024A (en) * 1977-10-16 1992-10-20 Strategic Medical Research Corporation Method of enhancing the activity of phagocytes including macrophages, modulating the cellular or humoral immune response, and reducing the adverse effects of stress in warm blooded animals
US4238482A (en) * 1978-09-29 1980-12-09 Peyman Gholam A Intraocular infusion irrigation solution and method
US4501729A (en) * 1982-12-13 1985-02-26 Research Corporation Aerosolized amiloride treatment of retained pulmonary secretions
LU84638A1 (fr) * 1983-02-10 1984-11-08 Oreal Composition capillaire contenant au moins un polymere cationique,un polymere anionique,un sucre et un sel
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
JPS6168418A (ja) * 1984-09-11 1986-04-08 Kanto Ishi Pharma Co Ltd 去痰薬
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
EP0240098A3 (de) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
US4981841A (en) * 1986-04-04 1991-01-01 Allergan, Inc. Methods and materials for use in corneal wound healing
US4826679A (en) * 1986-05-23 1989-05-02 Universite De Montreal Composition and methods for alleviating cystic fibrosis
DE3636590A1 (de) * 1986-10-28 1988-05-26 Braun Melsungen Ag Blutersatzmittel
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
US5037810A (en) * 1987-03-17 1991-08-06 Saliba Jr Michael J Medical application for heparin and related molecules
EP0285357A3 (de) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Bekämpfung von Retroviren
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
US5135919A (en) * 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
DK505588D0 (da) * 1988-02-26 1988-09-09 Jesper Hamburger Middel og anvendelse af samme
EP0333243A3 (de) * 1988-03-10 1989-09-27 Akzo N.V. Sulphatiertes K5-Antigen und seine Fragmente
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
DE3902021A1 (de) * 1989-01-20 1990-07-26 Entec Verwendung von antipeptidergen mitteln, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen prostatakarzinoms
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
WO1991015216A1 (en) * 1990-04-05 1991-10-17 Kennedy Thomas P Method and medicament for prevention or medication of human leucocyte elastase-mediated pulmonary diseases
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
US5221669A (en) * 1991-04-19 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
FR2682388B1 (fr) * 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
WO1993008810A1 (en) * 1991-11-05 1993-05-13 Carrington Laboratories, Inc. Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure
EP0650492A1 (de) * 1992-05-26 1995-05-03 Alberta Research Council Verminderung von entzündungen durch zeitabhängige verabreichung von blutgruppendeterminanten verwandten glykosid-oligosacchareden
US5384128A (en) * 1993-03-02 1995-01-24 University Of Alabama Research Foundation Method of and compounds for treatment for cystic fibrosis

Also Published As

Publication number Publication date
ES2133722T3 (es) 1999-09-16
US5514665A (en) 1996-05-07
DE69417920D1 (de) 1999-05-20
GR3032116T3 (en) 2000-04-27
CA2180352A1 (en) 1995-07-06
EP0737072A1 (de) 1996-10-16
EP0737072B1 (de) 1999-04-14
DE69417920T2 (de) 1999-11-04
CA2180352C (en) 2007-03-20
AU1377995A (en) 1995-07-17
WO1995017898A1 (en) 1995-07-06
DK0737072T3 (da) 1999-11-01

Similar Documents

Publication Publication Date Title
ATE178798T1 (de) Verwendung vor einfachern oder conjugiertem dextran zur herstellung eines medikaments zur vorbeugung oder verminderung des risikos einer bacterieller pathogener infektion
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
EA200200059A1 (ru) Комбинация молочнокислых бактерий и ее применение для профилактики и/или лечения инфекций и воспалительных состояний
WO1989006649A3 (en) Antibacterial agents
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
DE59410052D1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
CA2184886A1 (en) Method of strengthening antibacterial action of antibiotics
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
KR890001534A (ko) 항균제 fr109615 및 이의 제조방법
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
SE7609181L (sv) Polyaminforeningar
AU2904700A (en) Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
ATE337002T1 (de) Topische behandlung zur vorbeugung von augeninfektionen
BR0212143A (pt) Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
AU1777595A (en) Methods for treating neurofibromatosis
NO872331L (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
AU1022688A (en) Antibacterial lyophilized preparation
WO2002074287A3 (en) Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics
WO2024147763A3 (en) Antimicrobial conjugated oligoelectrolytes and methods thereof
Reddy et al. Bacteriological studies in healthy eyes and corneal ulcers.
HU9300553D0 (en) Complex antibiotic ge1655 its a, d and c factors, method for producing them, agricultural and pharmaceutical preparatives containing them as well as method for preparing said preparatives
WO1992018090A3 (en) Antimicrobial oral compositions

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee